AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Total Non-Current Liabilities (2020 - 2026)

Updated

AbCellera Biologics (ABCL) recorded Total Non-Current Liabilities of $358.37 million in Q2 2026, up 9.3% from $327.96 million a year earlier and up 11.4% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, AbCellera Biologics reported Total Non-Current Liabilities of $325.74 million, up 43.0% from FY2024.

  • Annual Total Non-Current Liabilities has increased for five straight years, with a five-year compound annual growth rate of 35.4% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $227.86 million in FY2024 (+5.1%), $216.76 million in FY2023 (+14.5%), $189.31 million in FY2022 (+10.0%) and $172.16 million in FY2021 (+140.7%).
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2020.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for 19 consecutive quarters, with growth averaging 22.8% over the last eight quarters.
  • The year-over-year growth in Total Non-Current Liabilities has ranged between 3.4% (Q2 2024) and 140.7% (Q4 2021) over the last five years.
  • Per Business Quant, the preceding three quarters came in at $321.74 million (Q1 2026), $325.74 million (Q4 2025) and $323.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 105.99 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 106.45 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -967.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.92 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn - 358.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 358.37 Mn
Mar 31, 2026 321.74 Mn
Dec 31, 2025 325.74 Mn
Sep 30, 2025 323.15 Mn
Jun 30, 2025 327.96 Mn
Mar 31, 2025 245.83 Mn
Dec 31, 2024 227.86 Mn
Sep 30, 2024 235.17 Mn
Jun 30, 2024 231.13 Mn
Mar 31, 2024 228.30 Mn
Dec 31, 2023 216.76 Mn
Sep 30, 2023 219.18 Mn
Jun 30, 2023 223.43 Mn
Mar 31, 2023 199.83 Mn
Dec 31, 2022 189.31 Mn
Sep 30, 2022 196.19 Mn
Jun 30, 2022 159.79 Mn
Mar 31, 2022 171.36 Mn
Dec 31, 2021 172.16 Mn
Sep 30, 2021 169.79 Mn
API Access

AbCellera Biologics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABCL&period=max&api_key=YOUR_API_KEY